EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Bone-Targeting Antibodies for Skeletal Precision Therapy

Boyang Zhou, Han Xiao iD

Bioconjugate Chemistry · 2026

DOI: 10.1021/acs.bioconjchem.6c00415 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioconjugate Chemistry, 2026. Verfasst von Boyang Zhou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Rice University, 6100 Main Street, Houston, Texas77005, United States. Hauptthemen laut MEDLINE: Bone and Bones, Antibodies, Bone Neoplasms, Precision Medicine. Die Arbeit nennt 22 Literaturangaben. Gefördert von: Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation, Cancer Prevention and Research Institute of Texas, National Institutes of Health (NIH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic antibodies have transformed the treatment of cancer, inflammation, infection, and disorders of bone biology by recognizing disease-associated molecular targets with high specificity. However, achieving therapeutically effective antibody concentrations at the site of disease remains a major challenge, as systemic administration does not inherently result in efficient tissue-specific delivery. Bone is a particularly demanding destination because mineralized matrix, limited vascular access, marrow complexity, and active remodeling can restrict local antibody exposure. Recent advances in bone-targeting antibody design point to a powerful reframing in which antibodies can be engineered not only for antigen specificity but also for tissue specificity. By attaching hydroxyapatite-binding motifs such as bisphosphonates or acidic peptides, antibodies can be endowed with bone-homing capabilities. The efficacy of this strategy has now been validated across multiple preclinical disease models, including breast cancer bone metastasis and osteoporosis-related bone loss. The next challenge is to define how affinity, valency, conjugation site, circulation time, and release should be tuned for each skeletal disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone and BonesAntibodiesBone NeoplasmsPrecision MedicineBone DiseasesHumansAnimals

Substanzen

Antibodies

Autor:innen und Institutionen

  • Department of Chemistry, Rice University, 6100 Main Street, Houston, Texas77005, United States.
  • Department of Biosciences, Rice University, 6100 Main Street, Houston, Texas77005, United States.
  • Department of Bioengineering, Rice University, 6100 Main Street, Houston, Texas77005, United States.
  • SynthX Center, Rice University, 6100 Main Street, Houston, Texas77005, United States.

ORCID-Profile: Han Xiao

Förderung

  • Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation
  • Cancer Prevention and Research Institute of Texas
  • National Institutes of Health (NIH)
  • Welch Foundation
  • U.S. Department of Defense

Zitieren

APA

Zhou, B., & Xiao, H. (2026). Bone-Targeting Antibodies for Skeletal Precision Therapy. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.6c00415

Vancouver

Zhou B, Xiao H. Bone-Targeting Antibodies for Skeletal Precision Therapy. Bioconjugate Chemistry. 2026. doi:10.1021/acs.bioconjchem.6c00415

BibTeX
@article{Zhou2026,
  author = {Zhou, Boyang and Xiao, Han},
  title = {Bone-Targeting Antibodies for Skeletal Precision Therapy},
  journal = {Bioconjugate Chemistry},
  year = {2026},
  doi = {10.1021/acs.bioconjchem.6c00415}
}
Kostenlos starten →